Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response von Earp, Justin C, Mehrotra, Nitin, Peters, Kristina E, Fiorentino, Robert P, Griebel, Donna, Lee, Sue C, Mulberg, Andrew, Röhss, Kerstin, Sandström, Marie, Taylor, Amy, Tornøe, Christoffer W, Wynn, Erica L, Van der Walt, Jan-Stefan, Garnett, Christine

Volltext

Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors von Katz, Philip, Kahrilas, Peter J., Johnson, David A., Lind, Tore, Röhss, Kerstin, Traxler, Barry, Hugo, Vincent, Dent, John

Volltext

Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease von RÖHSS, Kerstin, HASSELGREN, Göran, HEDENSTRÖM, Hans

Volltext

Acid Control Cannot Be Improved with a Modified-Release Formulation of a Proton Pump Inhibitor Compared with Twice-Daily Dosing of the Conventional Formulation von Röhss, Kerstin, Wilder-Smith, Clive, Bokelund-Singh, Sara, Sagar, Mohamed, Nagy, Péter

Volltext

Prevention of Relapse of Healed Reflux Esophagitis is Related to the Duration of Intragastric pH>4 von Johnson, David A, Katz, Philip O, Levine, Doug, Röhss, Kerstin, Åstrand, Magnus, Junghard, Ola, Nagy, Péter

Volltext

Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole von Andersson, Tommy, Holmberg, Johan, Walan, Anders

Volltext

Acid control with esomeprazole and lansoprazole: A comparative dose-response study von Wilder-Smith, Clive, Lind, Tore, Lundin, Christina, Nauclér, Emma, Nilsson-Pieschl, Catharina, Röhss, Kerstin

Volltext

Effect of Increasing Esomeprazole and Pantoprazole Doses on Acid Control in Patients with Symptoms of Gastro-Oesophageal Reflux Disease: A Randomized, Dose-Response Study von Wilder-Smith, Clive, Backlund, Anna, Eckerwall, Göran, Lind, Tore, Fjellman, Mia, Röhss, Kerstin

Volltext

Esomeprazole 20mg provides more effective intragastric Acid control than maintenance-dose rabeprazole, lansoprazole or pantoprazole in healthy volunteers von Röhss, Kerstin, Wilder-Smith, Clive, Nauclér, Emma, Jansson, Lennart

Volltext

Esomeprazole 40 mg Provides Improved Intragastric Acid Control as Compared with Lansoprazole 30 mg and Rabeprazole 20 mg in Healthy Volunteers von Wilder-Smith, Clive H., Röhss, Kerstin, Nilsson-Pieschl, Catharina, Junghard, Ola, Nyman, Lars

Volltext

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole von ANDERSSON, Tommy, HASSAN-ALIN, Mohammed, HASSELGREN, Göran, RÖHSS, Kerstin, WEIDOLF, Lars

Volltext

Esomeprazole FDA Approval in Children With GERD von Earp, Justin C., Mehrotra, Nitin, Peters, Kristina E., Fiorentino, Robert P., Griebel, Donna, Lee, Sue C., Mulberg, Andrew, Röhss, Kerstin, Sandström, Marie, Taylor, Amy, Tornøe, Christoffer W., Wynn, Erica L., Van der Walt, Jan‐Stefan, Garnett, Christine

Volltext

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oes... von RÖHSS, Kerstin, LIND, Tore, WILDER-SMITH, Clive

Volltext

Daytime intragastric acid control: analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors von Philip Katz, Peter J. Kahrilas, David A. Johnson, Tore Lind, Kerstin Röhss, Barry Traxler, Vincent Hugo, John Dent

Volltext

Intravenous Esomeprazole 40mg is Effective for the Control of Intragastric Acid Levels Whether Given as a 3-Minute Injection or a 30-Minute Infusion von Wilder-Smith, Clive, Röhss, Kerstin, Bondarov, Patrik, Hassan-Alin, Mohammed, Lundin, Christina, Niazi, Mohammad, Nilsson-Pieschl, Catharina, Ahlbom, Henrik

Volltext

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole von ANDERSSON, Tommy, HASSAN-ALIN, Mohammed, HASSELGREN, Göran, RÖHSS, Kerstin

Volltext

Pharmacokinetic study of Esomeprazole in the elderly von HASSELGREN, Göran, HASSAN-ALIN, Mohammed, ANDERSSON, Tommy, CLAAR-NILSSON, Catharina, RÖHSS, Kerstin

Volltext

Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies von Wilder-Smith, Clive H, Bondarov, Patrik, Lundgren, Marie, Niazi, Mohammad, Röhss, Kerstin, Ahlbom, Henrik, Nyman, Lars

Volltext

Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunction von PIQUE, Josep M, FEU, Faust, DE PRADA, Gloria, RÖHSS, Kerstin, HASSELGREN, Göran

Volltext

Pharmacokinetics of Esomeprazole Following Varying Intravenous Administration Rates von Niazi, Mohammad, Ahlbom, Henrik, Bondarov, Patrik, Karlsson, Anna H., Hassan‐Alin, Mohammed, Rydholm, Hans, Röhss, Kerstin

Volltext